Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review
Jacques Suspène, Sarah Huet, Sabine Berteina‐raboin, Amine Benyamina, Patrick Baril, Séverine Morisset‐lopez, Raphaël Serreau
Qeios December 9, 2025 DOI: 10.32388/xcfsag.2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Addiction Psilocybin |
| Keywords | Craving Abstinence Alcohol consumption Hallucinogen Clinical trial Substance use Clinical psychology |
| Key findings | Psilocybin seems to reduce craving for alcohol, but its effect on overall alcohol consumption is less clear. |
Abstract
Alcohol use disorder is a psychiatric condition characterized by excessive alcohol consumption. The drugs that are used to treat it often fail to prevent relapse. At the same time, psilocybin is increasingly being investigated for the treatment of various substance use disorders. This review aims to evaluate the results of the most recent clinical trials assessing psilocybin as a treatment for alcohol use disorder. According to these trials, psilocybin seems to reduce craving but its effect on overall alcohol consumption is less clear. There is no doubt that future trials would benefit from larger sample sizes and standardized tests.